Table 4.

Influence of crystalloid infusion on hypotension during lipoprotein apheresis (LA) treatment.

	Symptomatic hypotension during apheresis (n = 22)	Apheresis session without hypotension (n = 272)	P
Crystalloid infusion	14 (63.63%)	54 (19.85%)	< 0.001
Crystalloid infusion before procedure	8 (36.36%)	39 (14.34%)	0.01
Crystalloid infusion during procedure	9 (40.91%)	20 (7.35%)	< 0.001
Blood flow at start of LA [mL/min]	52.86 ± 9.16	50.81 ± 8.71	0.3
Blood flow 2 at the end of LA [mL/min]	96.00 ± 29.00	101.17 ± 20.25	0.4

Data for blood flow are presented as mean ± standard deviation.